Publication:
Identification of novel prostate cancer genes in patients stratified by Gleason classification: Role of antitumoral genes.

Loading...
Thumbnail Image

Date

2022-02-16

Authors

Diaz de la Guardia-Bolivar, Elisa
Barrios-Rodriguez, Rocio
Zwir, Igor
Jimenez-Moleon, Jose Juan
Del Val, Coral

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

John Wiley & Sons, Inc.
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Prostate cancer (PCa) is a tumor with a great heterogeneity, both at a molecular and clinical level. Despite its global good prognosis, cases can vary from indolent to lethal metastatic and scientific efforts are aimed to discern those with worse outcomes. Current prognostic markers, as Gleason score, fall short when it comes to distinguishing these cases. Identification of new early biomarkers to enable a better PCa distinction and classification remains a challenge. In order to identify new genes implicated in PCa progression we conducted several differential gene expression analyses over paired samples comparing primary PCa tissue against healthy prostatic tissue of PCa patients. The results obtained show that this approach is a serious alternative to overcome patient heterogeneity. We were able to identify 250 genes whose expression varies along with tissue differentiation-healthy to tumor tissue, 161 of these genes are described here for the first time to be related to PCa. The further manual curation of these genes allowed to annotate 39 genes with antitumoral activity, 22 of them described for the first time to be related to PCa proliferation and metastasis. These findings could be replicated in different cohorts for most genes. Results obtained considering paired differential expression, functional annotation and replication results point to: CGREF1, UNC5A, C16orf74, LGR6, IGSF1, QPRT and CA14 as possible new early markers in PCa. These genes may prevent the progression of the disease and their expression should be studied in patients with different outcomes.

Description

MeSH Terms

Biomarkers, Tumor
Humans
Immunoglobulins
Male
Membrane Proteins
Neoplasm Grading
Prognosis
Prostate
Prostatic Neoplasms

DeCS Terms

Biomarcadores de tumor
Clasificación del tumor
Humanos
Inmunoglobulinas
Masculino
Neoplasias de la próstata
Pronóstico
Proteínas de la membrana
Próstata

CIE Terms

Keywords

antitumoral genes, biomarkers, prostate cancer

Citation

Díaz de la Guardia-Bolívar E, Barrios-Rodríguez R, Zwir I, Jiménez-Moleón JJ, Del Val C. Identification of novel prostate cancer genes in patients stratified by Gleason classification: Role of antitumoral genes. Int J Cancer. 2022 Jul 15;151(2):255-264.